These oncogenes are observed in NSCLC and other cancer types, but no murine models and limited RET+ and NTRK+ human cell lines exist (Drilon et al., 2018; Kohno et al., 2012; Lipson et al., 2012; Schubert et al., 2021; Takeuchi et al., 2012; Vaishnavi et al., 2013). The gene discussed is RET; the disease is cancer.